Aptamer-functionalized nanoparticles for medical applications: Challenges and opportunities

ACS Nano

Volumn 6, Issue 5, 2012, Pages 3670-3676

  Xiao, Zeyu ^a   Farokhzad, Omid C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMERS; CLINICAL DEVELOPMENT; DIAGNOSTIC APPLICATIONS; IN-VIVO; INTRINSIC PROPERTY; PROOF-OF-CONCEPT DESIGN; RECENT PROGRESS;

MEDICAL APPLICATIONS; MEDICAL NANOTECHNOLOGY;

NANOPARTICLES;

APTAMER; NANOPARTICLE;

HUMAN; MAGNETISM; NEOPLASM; NOTE; PATHOLOGY;

APTAMERS, NUCLEOTIDE; HUMANS; MAGNETICS; NANOPARTICLES; NEOPLASMS;

EID: 84864708256     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn301869z     Document Type: Article

References (48)

1. Cullen, B. R.; Greene, W. C. Regulatory Pathways Governing HIV-1 Replication. Cell 1989, 58, 423-426.
2. Ellington, A. D.; Szostak, J. W. In Vitro Selection of RNA Molecules That Bind Specific Ligands. Nature 1990, 346, 818-822.
3. Tuerk, C.; Gold, L. Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA Polymerase. Science 1990, 249, 505-510.
4. Daniels, D. A.; Chen, H.; Hicke, B. J.; Swiderek, K. M.; Gold, L. A Tenascin-C Aptamer Identified by Tumor Cell SELEX: Systematic Evolution of Ligands by Exponential Enrichment. Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 15416-15421.
5. Shangguan, D.; Li, Y.; Tang, Z.; Cao, Z. C.; Chen, H. W.; Mallikaratchy, P.; Sefah, K.; Yang, C. J.; Tan, W. Aptamers Evolved from Live Cells as Effective Molecular Probes for Cancer Study. Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 11838-11843.
6. Mi, J.; Liu, Y.; Rabbani, Z. N.; Yang, Z.; Urban, J. H.; Sullenger, B. A.; Clary, B. M. In Vivo Selection of Tumor-Targeting RNA Motifs. Nat. Chem. Biol. 2010, 6, 22-24.
7. Xiao, Z.; Levy-Nissenbaum, E.; Alexis, F.; Luptak, A.; Teply, B. A.; Chan, J. M.; Shi, J.; Digga, E.; Cheng, J.; Langer, R.; et al. Engineering of Targeted Nanoparticles for Cancer Therapy Using Internalizing Aptamers Isolated by Cell-Uptake Selection. ACS Nano 2012, 6, 696-704.
8. Ferrari, M. Cancer Nanotechnology: Opportunities and Challenges. Nat. Rev. Cancer 2005, 5, 161-171.
9. Farokhzad, O. C.; Langer, R. Impact of Nanotechnology on Drug Delivery. ACS Nano 2009, 3, 16-20.
10. Davis, M. E.; Chen, Z. G.; Shin, D. M. Nanoparticle Therapeutics: An Emerging Treatment Modality for Cancer. Nat. Rev. Drug Discovery 2008, 7, 771-782.
11. Kamaly, N.; Xiao, Z.; Valencia, P. M.; Radovic-Moreno, A. F.; Farokhzad, O. C. Targeted Polymeric Therapeutic Nanoparticles: Design, Development and Clinical Translation. Chem. Soc. Rev. 2012, 41, 2971-3010.
12. Farokhzad, O. C.; Jon, S.; Khademhosseini, A.; Tran, T. N.; Lavan, D. A.; Langer, R. Nanoparticle-Aptamer Bioconjugates: A New Approach for Targeting Prostate Cancer Cells. Cancer Res. 2004, 64, 7668-7672.
13. Bamrungsap, S.; Chen, T.; Shukoor, M. I.; Chen, Z.; Sefah, K.; Chen, Y.; Tan, W. Pattern Recognition of Cancer Cells Using Aptamer-Conjugated Magnetic Nanoparticles. ACS Nano 2012, 10.1021/nn3002328.
14. Cao, Z.; Tong, R.; Mishra, A.; Xu, W.; Wong, G. C.; Cheng, J.; Lu, Y. Reversible Cell-Specific Drug Delivery with Aptamer-Functionalized Liposomes. Angew. Chem., Int. Ed. 2009, 48, 6494-6498.
15. Zhu, Z.; Tang, Z.; Phillips, J. A.; Yang, R.; Wang, H.; Tan, W. Regulation of Singlet Oxygen Generation Using Single-Walled Carbon Nanotubes. J. Am. Chem. Soc. 2008, 130, 10856-10857.
16. Gu, F.; Zhang, L.; Teply, B. A.; Mann, N.; Wang, A.; Radovic-Moreno, A. F.; Langer, R.; Farokhzad, O. C. Precise Engineering of Targeted Nanoparticles by Using Self-Assembled Biointegrated Block Copolymers. Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 2586-2591.
17. Farokhzad, O. C.; Karp, J. M.; Langer, R. Nanoparticle-Aptamer Bioconjugates for Cancer Targeting. Expert Opin. Drug Delivery 2006, 3, 311-324.
18. Keefe, A. D.; Pai, S.; Ellington, A. Aptamers as Therapeutics. Nat. Rev. Drug Discovery 2010, 9, 537-550.
19. Wu, Y.; Phillips, J. A.; Liu, H.; Yang, R.; Tan, W. Carbon Nanotubes Protect DNA Strands during Cellular Delivery. ACS Nano 2008, 2, 2023-2028.
20. Seferos, D. S.; Prigodich, A. E.; Giljohann, D. A.; Patel, P. C.; Mirkin, C. A. Polyvalent DNA Nanoparticle Conjugates Stabilize Nucleic Acids. Nano Lett. 2009, 9, 308-311.
21. Pendergrast, P. S.; Marsh, H. N.; Grate, D.; Healy, J. M.; Stanton, M. Nucleic Acid Aptamers for Target Validation and Therapeutic Applications. J. Biomol. Tech. 2005, 16, 224-234.
22. Dua, P.; Kim, S.; Lee, D. K. Patents on SELEX and Therapeutic Aptamers. Recent Pat. DNA Gene Sequences 2008, 2, 172-186.
23. Senter, P. D.; Springer, C. J. Selective Activation of Anticancer Prodrugs by Monoclonal Antibody-Enzyme Conjugates. Adv. Drug Delivery Rev. 2001, 53, 247-264.
24. Wu, Y.; Sefah, K.; Liu, H.; Wang, R.; Tan, W. DNA Aptamer-Micelle as an Efficient Detection/Delivery Vehicle toward Cancer Cells. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 5-10.
25. Huang, Y. F.; Chang, H. T.; Tan, W. Cancer Cell Targeting Using Multiple Aptamers Conjugated on Nanorods. Anal. Chem. 2008, 80, 567-572.
26. Nucleic Acid Aptamers for Diagnostic and Therapeutics: Global Markets, Bio071, www.bccresearch.com.
27. Li, N.; Larson, T.; Nguyen, H. H.; Sokolov, K. V.; Ellington, A. D. Directed Evolution of Gold Nanoparticle Delivery to Cells. Chem. Commun. 2010, 46, 392-394.
28. Kim, D.; Jeong, Y. Y.; Jon, S. A Drug-Loaded Aptamer-Gold Nanoparticle Bioconjugate for Combined CT Imaging and Therapy of Prostate Cancer. ACS Nano 2010, 4, 3689-3696.
29. Yu, M. K.; Kim, D.; Lee, I. H.; So, J. S.; Jeong, Y. Y.; Jon, S. Image-Guided Prostate Cancer Therapy Using Aptamer-Functionalized Thermally Cross-Linked Superparamagnetic Iron Oxide Nanoparticles. Small 2011, 7, 2241-2249.
30. Dhar, S.; Kolishetti, N.; Lippard, S. J.; Farokhzad, O. C. Targeted Delivery of a Cisplatin Prodrug for Safer and More Effective Prostate Cancer Therapy in Vivo. Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 1850-1855.
31. Farokhzad, O. C.; Cheng, J.; Teply, B. A.; Sherifi, I.; Jon, S.; Kantoff, P. W.; Richie, J. P.; Langer, R. Targeted Nanoparticle-Aptamer Bioconjugates for Cancer Chemotherapy in Vivo. Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 6315-6320.
32. Kurosaki, T.; Higuchi, N.; Kawakami, S.; Higuchi, Y.; Nakamura, T.; Kitahara, T.; Hashida, M.; Sasaki, H. Self-Assemble Gene Delivery System for Molecular Targeting Using Nucleic Acid Aptamer. Gene 2012, 491, 205-209.
33. Yu, C.; Hu, Y.; Duan, J.; Yuan, W.; Wang, C.; Xu, H.; Yang, X. D. Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of Anticancer Drug to MUC1-Positive Cancer Cells in Vitro. PLoS One 2011, 6, e24077.
34. Chang, M.; Yang, C. S.; Huang, D. M. Aptamer-Conjugated DNA Icosahedral Nanoparticles as a Carrier of Doxorubicin for Cancer Therapy. ACS Nano 2011, 5, 6156-6163.
35. Li, J.; Xu, M.; Huang, H.; Zhou, J.; Abdel-Halimb, E. S.; Zhang, J. R.; Zhu, J. J. Aptamer-Quantum Dots Conjugates-Based Ultrasensitive Competitive Electrochemical Cytosensor for the Detection of Tumor Cell. Talanta 2011, 85, 2113-2120.
36. Zhu, C. L.; Lu, C. H.; Song, X. Y.; Yang, H. H.; Wang, X. R. Bioresponsive Controlled Release Using Mesoporous Silica Nanoparticles Capped with Aptamer-Based Molecular Gate. J. Am. Chem. Soc. 2011, 133, 1278-1281.
37. Zhong, H.; Zhang, Q.; Zhang, S. High-Intensity Fluorescence Imaging and Sensitive Electrochemical Detection of Cancer Cells by Using an Extracellular Supramolecular Reticular DNA-Quantum Dot Sheath. Chemistry 2011, 17, 8388-8394.
38. Liu, G.; Mao, X.; Phillips, J. A.; Xu, H.; Tan, W.; Zeng, L. Aptamer-Nanoparticle Strip Biosensor for Sensitive Detection of Cancer Cells. Anal. Chem. 2009, 81, 10013-10018.
39. Medley, C. D.; Smith, J. E.; Tang, Z.; Wu, Y.; Bamrungsap, S.; Tan, W. Gold Nanoparticle-Based Colorimetric Assay for the Direct Detection of Cancerous Cells. Anal. Chem. 2008, 80, 1067-1072.
40. Huang, Y. F.; Sefah, K.; Bamrungsap, S.; Chang, H. T.; Tan, W. Selective Photothermal Therapy for Mixed Cancer Cells Using Aptamer-Conjugated Nanorods. Langmuir 2008, 24, 11860-11865.
41. Herr, J. K.; Smith, J. E.; Medley, C. D.; Shangguan, D.; Tan, W. Aptamer-Conjugated Nanoparticles for Selective Collection and Detection of Cancer Cells. Anal. Chem. 2006, 78, 2918-2924.
42. Chen, T.; Shukoor, M. I.; Wang, R.; Zhao, Z.; Yuan, Q.; Bamrungsap, S.; Xiong, X.; Tan, W. Smart Multifunctional Nanostructure for Targeted Cancer Chemotherapy and Magnetic Resonance Imaging. ACS Nano 2011, 5, 7866-7873.
43. He, X.; Hai, L.; Su, J.; Wang, K.; Wu, X. One-Pot Synthesis of Sustained-Released Doxorubicin Silica Nanoparticles for Aptamer Targeted Delivery to Tumor Cells. Nanoscale 2011, 3, 2936-2942.
44. Fan, Z.; Shelton, M.; Singh, A. K.; Senapati, D.; Khan, S. A.; Ray, P. C. Multifunctional Plasmonic Shell-Magnetic Core Nanoparticles for Targeted Diagnostics, Isolation, and Photothermal Destruction of Tumor Cells. ACS Nano 2012, 6, 1065-1073.
45. Beqa, L.; Fan, Z.; Singh, A. K.; Senapati, D.; Ray, P. C. Gold Nano-Popcorn Attached SWCNT Hybrid Nanomaterial for Targeted Diagnosis and Photothermal Therapy of Human Breast Cancer Cells. ACS Appl. Mater. Interfaces 2011, 3, 3316-3324.
46. Lu, W.; Arumugam, S. R.; Senapati, D.; Singh, A. K.; Arbneshi, T.; Khan, S. A.; Yu, H.; Ray, P. C. Multifunctional Oval-Shaped Gold-Nanoparticle-Based Selective Detection of Breast Cancer Cells Using Simple Colorimetric and Highly Sensitive Two-Photon Scattering Assay. ACS Nano 2010, 4, 1739-1749.
47. Hu, D.; Zhang, P.; Gong, P.; Lian, S.; Lu, Y.; Gao, D.; Cai, L. A Fast Synthesis of Near-Infrared Emitting CdTe/CdSe Quantum Dots with Small Hydrodynamic Diameter for In Vivo Imaging Probes. Nanoscale 2011, 3, 4724-4732.
48. Guo, J.; Gao, X.; Su, L.; Xia, H.; Gu, G.; Pang, Z.; Jiang, X.; Yao, L.; Chen, J.; Chen, H. Aptamer-Functionalized PEG-PLGA Nanoparticles for Enhanced Anti-Glioma Drug Delivery. Biomaterials 2011, 32, 8010-8020.